Evidence that arsenite acts as a cocarcinogen in skin cancer

Toxicology and Applied Pharmacology

Volumn 198, Issue 3, 2004, Pages 394-404

  Rossman, Toby G ^a   Uddin, Ahmed N ^a   Burns, Fredric J ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arsenic; DNA repair; Mouse; Proliferation; Skin cancer; Ultraviolet light

Indexed keywords

ARSENIC TRIOXIDE; DRINKING WATER;

ARGENTINA; BANGLADESH; CELL CYCLE; CHILE; DNA DAMAGE; GENOME; HUMAN; MEXICO; NONHUMAN; REVIEW; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE; SUNLIGHT; TAIWAN; ULTRAVIOLET IRRADIATION; UNITED STATES;

ANIMALS; ARSENIC POISONING; COCARCINOGENESIS; DNA REPAIR; HUMANS; MICE; SKIN NEOPLASMS; ULTRAVIOLET RAYS; WATER POLLUTION, CHEMICAL;

ANIMALIA;

EID: 3242749112     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.taap.2003.10.016     Document Type: Review

References (140)

1. Achanzar W.E., Brambila E.M., Diwan B.A., Webber M.M., Waalkes M.P. Inorganic arsenite-induced malignant transformation of human prostate epithelial cells. J. Natl. Cancer Inst. 94:2002;1888-1891
2. Alain G., Tousignant J., Rozenfarb E. Chronic arsenic toxicity. Int. J. Dermatol. 32:1993;899-901
3. Anderson K.C., Boise L.H., Louie R., Waxman S. Arsenic trioxide in multiple myeloma: rationale and future directions. Cancer J. 8:2002;12-25
4. Bachleitner-Hoffmann T., Kees M., Gisslinger H. Arsenic trioxide: acute promyelocytic leukemia and beyond. Leuk. Lymphoma. 43:2002;1535-1540
5. Barchowsky A., Roussel R.R., Klei L.R., James P.E., Ganju N., Smith K.R., Dudek E.J. Low levels of arsenic trioxide stimulate proliferative signals in primary vascular cells without activating stress effector pathways. Toxicol. Appl. Pharmacol. 159:1999;65-75
6. Basu A., Mahata J., Gupta S., Giri A.K. Genetic toxicology of a paradoxical human carcinogen, arsenic: a review. Mutat. Res. 488:2001;171-194
7. Basu A., Mahata J., Roy A.K., Sarlar J.N., Poddar G., Nandi A., Sarkar P.K., Dutta P.K., Banerjee A., Das M., Ray K., Roychaudhury S., Natarajan A.T., Nilsson R., Giri A.K. Enhanced frequency of micronuclei in individuals exposed to arsenic through drinking water in West Bengal, India. Mutat. Res. 516:2002;29-40
8. Beneke R., Geisen C., Zevnik B., Bauch T., Müller W.-U., Küpper J.-H., Möröy T. DNA excision repair and DNA damage-induced apoptosis are linked to poly(ADP-ribosyl)ation but have different requirements for p53. Mol. Cell. Biol. 20:2000;6695-6703
9. Borgono J.M., Vicent P., Venturino H., Infante A. Arsenic in the drinking water of the city of Antofagasta: epidemiological and clinical study before and after the installation of a treatment plant. Environ. Health Perspect. 19:1977;103-105
10. Bürkle A. Physiology and pathophysiology of poly(ADP-ribosyl)ation. BioEssays. 23:2001;795-806
11. Burns F.J., Uddin A.N., Wu F., Nadas A., Rossman T.G. Arsenic-Induced Enhancement of UV Carcinogenesis in Mouse Skin: A Dose-Response. Environ. Health Perspect. 2004;. (in press)
12. Cantor K.P. Drinking water and cancer. Cancer Causes Control. 8:1997;292-308
13. Cebrian M.E., Albores A., Aguilar M., Blakely E. Chronic arsenic poisoning in the north of Mexico. Hum. Toxicol. 2:1983;121-133
14. Centeno J.A., Mullick F.G., Martinex L., Page N.P., Gibb H., Longfellow D., Thompson C., Ladich E.R. Pathology related to chronic arsenic exposure. Environ. Health Perspect. 110:2002;883-886
15. Chen C.-J., Chen C.W., Wu M.-M., Kuo T.-L. Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Br. J. Cancer. 66:1992;888-892
16. Chen Y., Megosh L.C., Gilmour S.K., Sawicki J.A., O'Brien T.G. K6/ODC transgenic mice as a sensitive model for carcinogen identification. Toxicol. Lett. 116:2000;27-35
17. Chen Y.C., Guo Y.L., Su H., Hsueh Y.M., Smith T.J., Ryan L.M., Lee M.S., Chao S.C., Lee J.Y., Christiani D.C. Arsenic methylation and skin cancer risk in southwestern Taiwan. J. Occup. Environ. Med. 45:2003;241-248
18. Chiou H.-Y., Hsueh Y.-M., Liaw K.-F., Horng S.-F., Chiang M.-H., Pu Y.-S., Lin J.S.-N., Huang C.-H., Chen C.-J. Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. Cancer Res. 55:1995;1296-1300
19. Chou W.-C., Hawkins A.L., Barrett J.F., Griffin C.A., Dang C.V. Arsenic inhibition of telomerase transcription leads to genetic instability. J. Clin. Invest. 108:2001;1541-1547
20. de Gruijl F.R. Skin cancer and solar UV radiation. Eur. J. Cancer. 35:1999;2003-2009
21. Del Razo L.M., Garcia-Vargas G.G., Vargas H., Albores A., Gonsebatt M.E., Montero R., Ostrosky-Wegman P., Kelsh M., Cebrian M.E. Altered profile of urinary arsenic metabolites in adults with chronic arsenicism. Arch. Toxicol. 71:1997;211-217
22. Dulout F.N., Grillo C.A., Seoane A.I., Maderna C.R., Nilsson R., Vahter M., Darroudi F., Natarajan A.T. Chromosomal aberrations in peripheral blood lymphocytes from native Andean women and children from northwestern Argentina exposed to arsenic in drinking water. Mutat. Res. 370:1996;151-158
23. Eastmond D.A., Tucker J.D. Kinetochore localization in micronucleated cytokinesis-blocked Chinese hamster ovary cells a new and rapid assay for identifying aneuploidy-inducing agents. Mutat. Res. 224:1989;517-525
24. Everall J.D., Dowd P.M. Influence of environmental factors excluding ultra violet radiation on the incidence of skin cancer. Bull. Cancer. 65:1978;241-247
25. Fenech M., Crott J., Turner J., Brown S. Necrosis, apoptosis, cytostasis and DNA damage in human lymphocytes measure simultaneously within the cytokinesis-block micronucleus assay: description of the method and results for hydrogen peroxide. Mutagenesis. 14:1999;605-612
26. Gebel T.W. Genotoxicity of arsenical compounds. Int. J. Hyg. Environ. Health. 203:2001;249-262
27. Germolec D.R., Yoshida T., Gaido K., Wilmer J.L., Simeonova P.P., Kayama F., Burleson F., Dong W., Lange R.W., Luster M.I. Arsenic induces overexpression of growth factors in human keratinocytes. Toxicol. Appl. Pharmacol. 141:1996;308-318
28. Germolec D.R., Spalding J., Boorman G.A., Wilmer J.L., Yoshida T., Simeonova P.P., Bruccoleri A., Kayama F., Gaido K., Tennant R., Burleson F., Dong W., Lang R.W., Luster M.I. Arsenic can mediate skin neoplasia by chronic stimulation of keratinocyte-derived growth factors. Mutat. Res. 386:1997;209-218
29. Germolec D., Spalding J., Yu H.-S., Chen G.S., Simeonova P.O., Humble M.C., Bruccoleri A., Boorman G.A., Foley J.F., Yoshida T., Luster M.I. Arsenic enhancement of skin neoplasia by chronic stimulation of growth factors. Am. J. Pathol. 153:1998;1775-1785
30. Goering P.L., Aposhian H.V., Mass M.J., Cebrian M., Beck B.D., Waalkes M.P. The enigma of arsenic carcinogenesis: role of metabolism. Toxicol. Sci. 49:1999;5-14
31. Gonsebatt M.E., Vega L., Salazar A.M., Montero R., Guzman P., Blas J., Del Razo L.M., Garcia-Vargas G., Albores A., Cerbrian M.E., Kelsh M., Ostrosky-Wegman P. Cytogenetic effects in human exposure to arsenic. Mutat. Res. 386:1997;219-228
32. Guha-Mazumder D.N., Haque R., Ghosh N., De B.K., Santra A., Chakroborty D., Smith A.H. Arsenic levels in drinking water and the prevalence of skin lesions in West Bengal, India. Int. J. Epidemiol. 27:1998;871-877
33. Gurr J.-R., Lin Y.-C., Ho I.-C., Jan K.-J., Lee T.-C. Induction of chromatid breaks and tetraploidy in Chinese hamster ovary cells by treatment with soduim arsenite during the G2 phase. Mutat. Res. 319:1993;135-142
34. Guo H.R., Yu H.S., Hu H., Monson R.R. Arsenic in drinking water and skin cancers: cell-type specificity. Cancer Causes Control. 12:2001;909-916
35. Hainaut P. The tumor suppressor protein p53: a receptor to genotoxic stress that controls cell growth and survival. Curr. Opin. Oncol. 7:1995;76-82
36. Hamadeh H., Trouba K.J., Amin R.P., Afshari C.A., Germolec D. Coordination of altered DNA repair and damage pathways in arsenite-exposed keratinocytes. Toxicol. Sci. 69:2002;306-316
37. Haque R., Guha Mazumder D.N., Samanta S., Ghosh N., Kalman D., Smith M.M., Mitra S., Santra A., Lahiri S., Das S., De B.K., Smith A.H. Arsenic in drinking water and skin lesions: dose-response data from West Bengal, India. Epidemiology. 14:2003;174-182
38. Harrington J.M., Middaugh J.P., Morse D.L., Howsworth J. A survey of a population exposed to high concentrations of arsenic in well water in Fairbanks, Alaska. Am. J. Epidemiol. 108:1978;377-385
39. Hartwig A., Groblinghoff U.D., Beyersmann D., Natarajan A.T., Filon R., Mullenders L.H.F. Interaction of arsenic(III) with nucleotide excision repair in UV-irradiated human fibroblasts. Carcinogenesis. 18:1997;399-405
40. Hartwig A., Asmuss M., Ehleben I., Herzer U., Kostelac D., Pelzer A., Schgwerdtle T., Burkle A. Interference by toxic metal ions with DNA repair processes and cell cycle control: molecular mechanisms. Environ. Health Perspect. 110:2002;797-799
41. Hartwig A., Pelzer A., Asmuss M., Burkle A. Very low concentrations of arsenite suppress poly(ADP-ribosyl)ation in mammalian cells. Int. J. Cancer. 104:2003;1-6
42. Hei T.K., Liu S.X., Waldren C. Mutagenicity of arsenic in mammalian cells: role of reactive oxygen species. Proc. Natl. Acad. Sci. U.S.A. 95:1998;8103-8107
43. Hopenhayn-Rich C., Biggs M.L., Smith A.H. Lung and kidney cancer mortality associated with arsenic in drinking water in Cordoba Argentina. Int. Epidemiol. Assoc. 27:1998;561-569
44. Hsueh Y.-M., Cheng G.-S., Wu M.-M., Yu H.-S., Kuo T.-L., Chen C.-J. Multiple risk factors associated with arsenic-induced skin cancer: effects of chronic liver disease and malnutritional status. Br. J. Cancer. 71:1995;109-114
45. Hsueh Y.-M., Chiou H.-Y., Huang Y.-L., Wu W.-L., Huang C.-C., Yang M.-H., Lue L.-C., Chen G.-S., Chen C.-J. Serum β-carotene level, arsenic methylation capability, and incidence of skin cancer. Cancer Epidemiol., Biomarkers Prev. 6:1997;589-596
46. Hsueh Y.-M., Ko Y.-F., Huang Y.-K., Chen H.-W., Chiou H.-Y., Huang Y.-L., Yang M.-H., Chen C.-J. Determinants of inorganic arsenic methylation capability among residents of the Lanyang Basin, Taiwan: arsenic and selenium exposure and alcohol consumption. Toxicol. Lett. 137:2003;49-63
47. Hu Y., Su L., Snow E.T. Arsenic toxicity is enzyme specific and its affects on ligation are not caused by the direct inhibition of DNA repair enzymes. Mutat. Res. 408:1998;203-218
48. Huang S.C., Lee T.C. Arsenite inhibits mitotic division and perturbs spindle dynamics in HeLa S3 cells. Carcinogenesis. 19:1998;889-896
49. Huang R.N., Ho I.C., Yih L.H., Lee T.C. Sodium arsenite induces chromosome endoreduplication and inhibits protein phosphatase activity in human fibroblasts. Environ. Mol. Mutagen. 25:1995;188-196
50. Huang C., Ma W.-Y., Li J., Goranson A., Dong Z. Requirement of Erk, but not JNK, for arsenite-induced cell transformation. J. Biol. Chem. 274:1999;14595-14601
51. IARC (International Agency for Research on Cancer) IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. Some Metals and Metallic Compounds. vol. 23:1980;39-141 World Health Organization, Lyon, France
52. Jha A.N., Noditi M., Nilsson R., Natarajan A.T. Genotoxic effects of sodium arsenite on human cells. Mutat. Res. 284:1992;215-221
53. Kadono T., Inaoka T., Murayama N., Ushijima K., Nagano M., Nakamura S., Watanabe C., Tamaki K., Ohtsuka R. Skin manifestations of arsenicosis in two villages in Bangladesh. Int. J. Dermatol. 41:2002;841-846
54. Kaminker P.G., Kim S.-H., Taylor R.D., Zebarjadian Y., Funk W.D., Morin G.B., Yaswen P., Campisi J. TANK2, a new TRF1-associated poly(ADP-ribose) polymerase, causes rapid induction of cell death upon overexpression. J. Biol. Chem. 276:2001;35891-35899
55. Karagas M.R., Stukel T.A., Morris J.S., Tosteson T.D., Weiss J.E., Spencer S.K., Greenberg E.R. Skin cancer risk in relation to toenail arsenic concentrations in a US population-based case-control study. Am. J. Epidemiol. 153:2001;559-565
56. Kenyon E.M., Hughes M.F. A concise review of the toxicity and carcinogenicity of dimethylarsinic acid. Toxicology. 160:2001;227-236
57. Kitchin K.T. Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites. Toxicol. Appl. Pharmacol. 172:2001;249-261
58. Kochhar T.S., Howard W., Hoffman S., Brammer-Carleton L. Effect of trivalent and pentavalent arsenic in causing chromosome alterations in cultured CHO cells. Toxicol. Lett. 84:1996;37-42
59. Lansdown A.B.G. Physiological and toxicological changes in the skin resulting from the action and interaction of metal ions. Crit. Rev. Toxicol. 25:1995;397-462
60. Lee T.-C., Huang R.Y., Jan K.Y. Sodium arsenite enhances the cytotoxicity clastogenicity and 6-thioguanine-resistant mutagenicity of ultraviolet light in Chinese hamster ovary cells. Mutat. Res. 148:1985;83-89
61. Lee T.C., Wang-Wuu S., Huang R.Y., Lee K.C., Jan K.Y. Differential effects of the pre- and post-treatment of sodium arsenite on the genotoxicity of methylmethanesulfonate in Chinese hamster ovary cells. Cancer Res. 46:1986;1854-1857
62. Lee T.-C., Lee K.C., Tseng Y.J., Huang R.Y., Jan K.Y. Sodium arsenite potentiates the clastogenicity and mutagenicity of DNA crosslinking agents. Environ. Mutagen. 8:1986;119-128
63. Lewis D.R., Southwich J.W., Ouellet-Hellstrom R., Rench J., Calderon R.L. Drinking water arsenic in Utah: a cohort mortality study. Environ. Health Perspect. 107:1999;359-365
64. Li J.-H., Rossman T.G. Mechanism of comutagenesis of sodium arsenite with N-methyl-N-nitrosourea. Biol. Trace Elem. Res. 21:1989;373-381
65. Li J.-H., Rossman T.G. Inhibition of DNA ligase activity by arsenite: a possible mechanism of its comutagenesis. Mol. Toxicol. 2:1989;1-9
66. Li J.-H., Rossman T.G. Comutagenesis of sodium arsenite with ultraviolet radiation in Chinese hamster V79 cells. Biol. Met. 4:1991;197-200
67. Liebscher K., Smith H. Essential and nonessential trace elements: a method of determining whether an element is essential or nonessential in human tissue. Arch. Environ. Health. 17:1968;881-890
68. Lin S., Cullen W.R., Thomas D.J. Methylarsenicals and arsinothiols are potent inhibitors of mouse liver thioredoxin reductase. Chem. Res. Toxicol. 12:1999;924-930
69. Livingstone L.R., White A., Sprouse J., Livanos E., Jacks T., Tlsty T.D. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell. 70:1992;923-935
70. Luster M.I., Wilmer J.L., Germolec D.R., Spalding J., Yoshida T., Gaido K., Simeonova P.P., Burleson F.G., Bruccoleri A. Role of keratinocyte-derived cytokines in chemical toxicity. Toxicol. Lett. 82/83:1995;471-476
71. Lynn S., Lai H.T., Gurr J.-R., Jan K.Y. Arsenite retards DNA strand break rejoining by inhibiting DNA ligation. Mutagenesis. 12:1997;353-358
72. Mahata J., Basu A., Ghoshal S., Sarkar J.N., Roy A.K., Poddar G., Nandy A.K., Banerjee A., Ray K., Natarajan A.T., Nilsson R., Giri A.K. Chromosomal aberrations and sister chromatid exchanges in individuals exposed to arsenic through drinking water in West Bengal, India. Mutat. Res. 534:2003;133-143
73. Maki-Paakkanen J., Kurttio P., Paldy A., Pekkanen J. Association between the clastogenic effect in peripheral lymphocytes and human exposure to arsenic through drinking water. Environ. Mol. Mutagen. 32:1998;301-313
74. Mandal B.K., Ogra Y., Suzuki K.T. Identification of dimethylarsinous and monomethylarsonous acids in human urine of the arsenic-affected areas in West Bengal, India. Chem. Res. Toxicol. 14:2001;371-378
75. Marafante E., Vahter M., Norin H., Envall J., Sandstrom M., Christakopoulos A., Ryhage R. Biotransformation of dimethylarsinic acid in mouse, hamster and man. J. Appl. Toxicol. 7:1987;111-117
76. Mass M.J., Wang L. Arsenic alters cytosine methylation patterns of the promoter of the tumor suppressor gene p53 in human lung cells: a model for a mechanism of carcinogenesis. Mutat. Res. 386:1997;263-277
77. Mass M.J., Tennant A., Roop B.C., Cullen W.R., Styblo M., Thomas D.J., Kligerman A.D. Methylated trivalent arsenic species are genotoxic. Chem. Res. Toxicol. 14:2001;355-361
78. 52 cells. Mutat. Res. 356:1996;255-259
79. Merwin J.R., Mustacich D.J., Muller E.G.D., Pearson G.D., Merrill G.F. Reporter gene transactivation by human p53 is inhibited in thioredoxin reductase null yeast by a mechanism associated with thioredoxin oxidation and independent of changes in the redox state of glutathione. Carcinogenesis. 23:2002;1609-1615
80. Miller W.H. Jr., Schipper H.M., Lee J.S., Singer J., Waxman S. Mechanisms of action of arsenic trioxide. Cancer Res. 62:2002;3893-3903
81. Milner J.E. The effects of ingested arsenic exposure on methyl cholanthrene induced skin tumours in mice. Arch. Environ. Health. 18:1969;7-11
82. Moore M.M., Harrington-Brock K., Doerr C.L. Relative genotoxic potency of arsenic and its methylated metabolites. Mutat. Res. 386:1997;279-290
83. Morton W., Starr G., Pohl D., Stoner J., Wagner S., Weswig P. Skin cancer and water arsenic in Lane County, Oregon. Cancer. 37:1976;2523-2532
84. Mure K., Uddin A., Lopez L.C., Styblo M., Rossman T.G. Arsenite induces delayed mutagenesis and transformation in human osteosarcoma cells at extremely low concentrations. Environ. Mol. Mutagen. 41:2003;322-331
85. National Research Council Arsenic in Drinking Water. 2000;National Academy Press, Washington, DC
86. Nesnow S., Roop B.C., Lambert G., Kadiiska M.B., Mason R.P., Cullen W.R., Mass M.J. DNA damage induced by methylated trivalent arsenicals is mediated by reactive oxygen species. Chem. Res. Toxicol. 15:2002;1627-1634
87. O'Brien T.G., Megosh L.C., Gillard G., Soler A.P. Ornithine decarboxylase overexpression is a sufficient condition for tumor promotion in mouse skin. Cancer Res. 57:1997;2630-2637
88. Okoji R.S., Yu R.C., Maronpot R.R., Froines J.R. Sodium arsenite administration via drinking water increases genome-side and Ha-ras DNA hypomethylation in methyl-deficient C57BL/6J mice. Carcinogenesis. 23:2002;777-785
89. Petrick J.S., Ayala-Fierro F., Cullen W.R., Carter D.E., Aposhian H.V. Monomethylarsonous acid (MMIII) is more toxic than arsenite in Chang human hepatocytes. Toxicol. Appl. Pharmacol. 163:2000;203-207
90. Petrick J.S., Jagadish B., Mash E.A., Aposhian H.V. Monomethylarsonous acid (MMA)(III) and arsenite: LD(50) in hamsters and in vitro inhibition of pyruvate dehydrogenase. Chem. Res. Toxicol. 14:2001;651-656
91. Pleschke J.M., Kleczkowska H.E., Strohm M., Althaus F.R. Poly(ADP-ribose) binds to specific domains in DNA damage checkpoint proteins. J. Biol. Chem. 29:2000;40974-40980
92. Ramirez P., Eastmond D.A., Laclette J.P., Ostrosky-Wegman P. Disruption of microtubule assembly and spindle formation for the induction of aneuploid cells by sodium arsenite and vanadium pentoxide. Mutat. Res. 386:1997;291-298
93. Reznikoff C.A., Belair C., Savelieva E., Zhai Y., Pfeifer K., Yeager T., Thompson K.J., DeVries S., Bindley C., Newton M.A. Long-term genome stability and minimal genotypic and phenotypic alterations in HPV16 E7-, but not E6-immortalized human uroepithelial cells. Genes Dev. 8:1994;2227-2240
94. Rossman T.G. Role of metals in carcinogenesis. Effects of metals on mutagenesis and DNA repair. Environ. Health Perspect. 40:1981;189-195
95. Rossman T.G. Molecular and genetic toxicology of arsenic. Rose J. Environmental Toxicology: Current Developments. 1998;171-187 Gordon and Breach Science, Amsterdam
96. Rossman T.G. Mechanism of arsenic carcinogenesis: an integrated approach. Mutat. Res. 533:2003;37-65
97. Rossman T.G., Visalli M.A., Uddin A.N., Hu Y. Human cell models for arsenic carcinogenicity and toxicity: transformation and genetic susceptibility. Chappell W.R., et al. Arsenic Exposure and Health Effects. 2001;285-295 Elsevier, New York
98. Rossman T.G., Uddin A.N., Burns F.J., Bosland M. Arsenic is a cocarcinogen with solar ultraviolet radiation for mouse skin: an animal model for arsenic carcinogenesis. Toxicol. Appl. Pharmacol. 176:2001;64-71
99. Rossman T.G., Uddin A.N., Burns F.J., Bosland M.C. Arsenite carcinogenesis: an animal model derived from genetic toxicology studies. Environ. Health Perspect. 110:2002;749-752
100. Rudolph K.L., Chang S., Lee H.-W., Blasco M., Gottlieb G., Greider C.W., DePinho R.A. Longevity, stress response, and cancer in aging telomerase deficient mice. Cell. 96:1999;1357-1365
101. Sciandrello G., Barbaro R., Caradonna F., Barbata G. Early induction of genetic instability and apoptosis by arsenic in cultured Chinese hamster cells. Mutagenesis. 17:2002;99-103
102. Shannon R.L., Strayer D.S. Arsenic-induced skin toxicity. Hum. Toxicol. 8:1989;99-104
103. Simbulan-Rosenthal C.M., Ly D.H., Rosenthal D.S., Konopka G., Luo R., Wang Z.-Q., Schultz P.G., Smulson M.E. Misregulation of gene expression in primary fibroblasts lacking poly (ADP-ribose) polymerase. Proc. Natl. Acad. Sci. 21:2000;11274-11279
104. Simeonova P.P., Luster M.I. Mechanisms of arsenic carcinogenicity: genetic or epigenetic mechanisms. J. Environ. Pathol., Toxicol. Oncol. 19:2000;281-286
105. Simeonova P.P., Wang S., Toriuma W., Kommineni V., Matheson J., Unimye N., Kayama F., Harki D., Ding M., Vallyathan V., Luster M.I. Arsenic mediates cell proliferation and gene expression in the bladder epithelium: association with activating protein-1 transactivation. Cancer Res. 60:2000;3445-3453
106. Smith S., de Lange T. Tankyrase promotes telomere elongation in human cells. Curr. Biol. 10:2000;1299-1302
107. Smith A.H., Hopenhayn-Rich C., Bates M.N., Goeden H.M., Hertz-Picciotto I.H., Duggan I., Wood R., Kosnett M., Smith M.T. Cancer risk from arsenic in drinking water. Environ. Health Perspect. 97:1992;259-267
108. Smith S., Giriart I., Schmitt A., de Lange T. Tankyrase, a poly(ADP-ribose) polymerase at human telomeres. Science. 282:1998;1484-1487
109. Styblo M., Serves S.V., Cullen W.R., Thomas D.J. Comparative inhibition of yeast glutathione reductase by arsenicals and arsenothiols. Chem. Res. Toxicol. 10:1997;27-33
110. Styblo M., Del Razo L.M., Vega L., Germolec D.R., LeCluyse E., Hamilton G.A., Reed W., Wang C., Cullen W.R., Thomas D.J. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch. Toxicol. 74:2000;289-299
111. Takahashi M., Barrett J.C., Tsutsui T. Transformation by inorganic arsenic compounds of normal Syrian hamster embryo cells into a neoplastic state in which they become anchorage-independent and cause tumors in newborn hamsters. Int. J. Cancer. 99:2002;629-634
112. Thomas D.J., Styblo M., Lin S. The cellular metabolism and systemic toxicity of arsenic. Toxicol. Appl. Pharmacol. 176:2001;127-144
113. Tian D., Ma H., Feng Z., Xia Y., Le X.C., Ni Z., Allen J., Collins B., Schreinemachers D., Mumford J.L. Analyses of micronuclei in exfoliated epithelial cells from individuals chronically exposed to arsenic via drinking water in inner Mongolia, China. J. Toxicol. Environ. Health. 64:2001;473-484
114. Tice R.R., Yager J.W., Andrews P., Crecelius E. Effect of hepatic methyl donor status on urinary excretion and DNA damage in B6C3F1 mice treated with sodium arsenite. Mutat. Res. 386:1997;315-334
115. Tinwell H., Stephens S.C., Ashby J. Arsenite as the probable active species in the human carcinogenicity of arsenic: mouse micronucleus assays on Na and K arsenite, orpiment, and Fowler's solution. Environ. Health Perspect. 95:1991;205-210
116. Tlsty T.D., Brot A., Gualberto A., Hall I., Hess S., Hixon M., Kuppuswamy D., Romanov S., Sage M., White A. Genomic instability and cancer. Mutat. Res. 337:1995;1-7
117. Tondel M., Rahman M., Magnuson A., Chowdhury I.A., Faruquee M.H., Ahmad S.A. The relationship of arsenic levels in drinking water and the prevalence rate of skin lesions in Bangladesh. Environ. Health Perspect. 107:1999;727-729
118. Trouba K.J., Wauson E.M., Vorce R.L. Sodium arsenite-induced dysregulation of proteins involved in proliferative signaling. Toxicol. Appl. Pharmacol. 164:2000;161-170
119. Tseng W.P. Effects and dose response relationships of skin cancer and blackfoot disease with arsenic. Environ. Health Perspect. 19:1977;109-119
120. Tseng W.P., Chu H.M., How S.W., Fong J.M., Lin C.S., Yeh S. Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J. Natl. Cancer Inst. 40:1968;453-463
121. Tsuda T., Babazono A., Yamamoto E., Kurumatani N., Mino Y., Ogara T., Kishi Y., Aoyama H. Ingested arsenic and internal cancer: a historical cohort study followed for 33 years. Am. J. Epidemiol. 141:1995;198-209
122. Vahter M., Concha G. Role of metabolism in arsenic toxicity. Pharmacol. Toxicol. 89:2001;1-5
123. van Wijk R., Welters M., Souren J.E.M., Ovelgonne H., Wiegant F.A.C. Serum-stimulated cell cycle progression and stress protein synthesis in C3H10T1/2 fibroblasts treated with sodium arsenite. J. Cell. Physiol. 155:1993;265-272
124. Vega L., Gonseblatt M.E., Ostrosky-Wegman P. Aneugenic effect of sodium arsenite on human lymphocytes in vitro: an individual susceptibility effect detected. Mutat. Res. 334:1995;365-373
125. Vega L., Styblo M., Patterson R., Cullen W., Wang C., Germolec D. Differential effects of trivalent and pentavalent arsenicals on cell proliferation and cytokine secretion in normal human epidermal keratinocytes. Toxicol. Appl. Pharmacol. 172:2001;225-232
126. Vogt B., Rossman T.G. Effects of arsenite on p53, p21 and cyclin D expression in normal human fibroblasts - A possible mechanism for arsenite's comutagenicity. Mutat. Res. 478:2001;159-168
127. Waalkes M.P., Ward J.M., Liu J., Diwan B.A. Transplacental carcinogenicity of inorganic arsenic in the drinking water: induction of hepatic, ovarian, pulmonary, and adrenal tumors in mice. Toxicol. Appl. Pharmacol. 186:2003;7-17
128. Warner M.L., Moore L.E., Smith M.T., Kalman D.A., Fanning E., Smith A.H. Increased micronuclei in exfoliated bladder cells of individuals who chronically ingest arsenic-contaminated water in Nevada. Cancer Epidemiol., Biomarkers Prev. 3:1994;583-590
129. Watanabe C., Inaoka T., Kadono T., Nagano M., Nakamura S., Ushijima K., Murayama N., Miyazaki K., Ohtsuka R. Males in rural Bangladeshi communities are more susceptible to chronic arsenic poisoning than females: analyses based on urinary arsenic. Environ. Health Perspect. 109:2001;1265-1270
130. Wei M., Wanibuchi H., Yamamoto S., Li W., Fukushima S. Urinary bladder carcinogenicity of dimethylarsinic acid in male F344 rats. Carcinogenesis. 20:1999;1873-1876
131. Wieler S., Gagne J.-P., Vaziri H., Poirier G.G., Benchimol S. Poly(ADP-ribose)polymerase-1 is a positive regulator of the p53-mediated G1 arrest response following ionizing radiation. J. Biol. Chem. 278:2003;18914-18921
132. Wiencke J.K., Yager J.W. Specificity of arsenite in potentiating cytogenetic damage induced by the DNA crosslinking agent diepoxybutane. Environ. Mol. Mutagen. 19:1992;195-200
133. Yager J.W., Wiencke J.K. Inhibition of poly(ADP-ribose) polymerase by arsenite. Mutat. Res. 386:1997;345-351
134. Yamanaka K., Katsumata K., Ikuma K., Hasegawa A., Nakano M., Okada S. The role of orally administered dimethylarsinic acid, a main metabolite of inorganic arsenics, in the promotion and progression of UVB-induced skin tumorigenesis in hairless mice. Cancer Lett. 152:2000;79-85
135. Yang J.L., Chen M.F., Wu C.W., Lee T.C. Posttreatment with sodium arsenite alters the mutation spectrum induced by ultraviolet light irradiation in Chinese hamster ovary cells. Environ. Mol. Mutagen. 20:1992;156-164
136. Yeh H. Skin cancer in chronic arsenic arsenicism. Hum. Pathol. 4:1973;469-485
137. Yih L.-H., Lee T.-C. Effects of exposure protocols on induction of kinetochore-plus and -minus micronuclei by arsenite in diploid human fibroblasts. Mutat. Res. 440:1999;75-82
138. Yu R.C., Hsu K.-H., Chen C.-J., Froines J.R. Arsenic methylation capacity and skin cancer. Cancer Epidemiol., Biomarkers Prev. 9:2000;1259-1262
139. Zhao C.Q., Young M.R., Diwan B.A., Coogan T.P., Waalkes M.P. Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc. Natl. Acad. Sci. U.S.A. 94:1997;10907-10912
140. Zhong C.X., Mass M.J. Both hypomethylation and hypermethylation of DNA associated with arsenite exposure in cultures of human cells identified by methylation-sensitive arbitrarily-primed PCR. Toxicol. Lett. 122:2001;223-234